Clinical Trials Browser

Phase 1/2 × Biliary Tract Neoplasms × Sorafenib × Clear all

NCT00955721 2018-01-03

A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer

Phase 1/2 Terminated

9 enrolled 7 charts

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma